Sympathetic physiology and pharmacology.
D000249:Adenosine Monophosphate / Q000502:physiology; D000255:Adenosine Triphosphate / Q000502:physiology; D000262:Adenylyl Cyclases / Q000502:physiology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D002395:Catecholamines / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology / Q000502:physiology; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007545:Isoproterenol / Q000502:physiology; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000097:blood / Q000494:pharmacology / Q000502:physiology; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014439:Tyramine / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D014642:Vanilmandelic Acid / Q000652:urine
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011955:Receptors, Drug; D000804:Angiotensin II; D000249:Adenosine Monophosphate; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D000255:Adenosine Triphosphate; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D002394:Catechol O-Methyltransferase; D000262:Adenylyl Cyclases; D004809:Ephedrine; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D006145:Guanethidine